StemoniX
Maple Grove, United States · Founded 2014
- Headquarters
- Maple Grove, Minnesota
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- stemonix.com
About
StemoniX developed ready-to-use human iPSC-derived 3D organoid platforms — including microBrain® and microHeart® — for high-throughput drug discovery, disease modeling, and toxicology screening. Founded in 2014 by Ping Yeh and Robert Petcavich, the company raised $17M across two rounds and operated out of Maple Grove, Minnesota. StemoniX's microBrain™ assets were acquired by AxoSim in October 2023 for $2.25M after the company became a subsidiary of Vyant Bio (formerly Cancer Genetics).
Summary
StemoniX is a Biotech company based in Maple Grove, United States, founded in 2014.
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Therapeutics company working in drug discovery and development using fungi with genomics approach...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/stemonix"><img src="https://indexed.vc/api/badge/company/stemonix" alt="StemoniX on Indexed.vc" width="260" height="76" /></a>